Upcoming activities
Past events
EUGOGO Global TED Forum 2025
EUGOGO Global TED Forum London 2025: A Resounding Success
The EUGOGO Global TED Forum 2025 in London brought together a record 300+ participants from across the globe, including ophthalmologists, endocrinologists, and other specialists — making it one of EUGOGO’s most successful meetings to date.
Feedback from delegates has been overwhelmingly positive:
- Over 90% rated the programme excellent for quality, organisation, and scientific relevance.
- 91% said the Forum fully met their educational goals.
- 85% plan to apply what they learned directly in clinical practice.
The meeting featured world-class presentations, expert panel discussions, and interactive sessions exploring the latest advances in pathogenesis, targeted therapies, surgical management, and multidisciplinary care.
Participants particularly praised the balance of evidence-based content, opportunities for discussion, and the high scientific integrity of the event.
EUGOGO extends heartfelt thanks to all faculty, participants, and sponsors whose support and contributions made this Forum a true success. Together, we continue to drive progress in understanding and treating Thyroid Eye Disease worldwide. We hope many of you can join us in Essen 7-8 March 2026!
Abstracts of the EUGOGO Global TED Forum 2025
Horizon scanning from panel discussions at the EUGOGO
Global TED Forum 2025 London
EUGOGO Symposium at the SOE Congress
7-9 June 2025
soe2025.abstractserver.com/program/#/details/sessions/66
The presentations at the EUGOGO Symposium “Updates on Graves’ Orbitopathy” at SOE Congress in Lisbon 7-9 June 2025 can be seen below:
International Symposium
Final program now available – click to download
Past webinars
12/2022: Early DON – a diagnostic challenge. -Christoph Hintschich (Munich), Stefano Fichera (Catania), Antonella Boschi (Brussels)
01/2023: Graves’ disease and Graves’ orbitopathy in times of COVID pandemic. -Milos Zarkovic (Serbia), Karim Meeran (London), Vickie Lee (London), Colin Dayan (Cardiff)
02/2023: Graves’ orbitopathy and Myasthenia gravis. -Onur Konuk (Ankara), Michael Schittkowski (Göttingen), Justin McKee (Edinburgh)
03/2023: Novel pathophysiological aspects of Graves’ disease/Graves’ orbitopathy. -Michele Marino (Pisa), Laurence du Pasquier (Paris)
04/2023: Ocular hypertension in Graves’ orbitopathy -to treat or not to treat? -Nicole Fichter (Olten), Jelena Juri Mandic (Zagreb), Antonella Boschi (Brussels)
07/2023: Orbital decompression surgery in Graves’ orbitopathy -anatomical/racial differences. -Lelio Baldeschi (Brussels), Gangadhara Sundar (Singapur), Katharina Ponto (Mainz)
10/2023: To correct diplopia in Graves’ orbitopathy -which muscle to choose -Anja Eckstein (Essen), Andrea Papp (Vienna), Nicola Curro (Milan)
12/2023: TSH receptor antibodies -how to measure and interprete. -Maria Cristina Burlacu (Brussels), Rosario Le Moli (Catania), Roland Gärtner (Munich)
04/2024: Medical and surgical outcomes of DON. -Gauthier Kielwasser (Lyon), Romain Manet (Lyon), Nicola Curro (Milan), Claudio Guastella (Milan)